Search results
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoPhase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligned with FDA feedback HB-200 accepted for oral abstract presentation
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 days agoNew York, USA, April 24, 2024 (GLOBE NEWSWIRE) -- HDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight According to DelveInsight’s analysis, the growth of the HDAC inhibitors market is expected
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...
HC Wainwright Reaffirms “Buy” Rating for Purple Biotech (NASDAQ:PPBT)
ETF DAILY NEWS· 2 days agoHC Wainwright reaffirmed their buy rating on shares of Purple Biotech (NASDAQ:PPBT – Free Report) in a report issued on Friday, Benzinga reports. HC Wainwright currently has a $10.00 price target ...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks· 2 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its late-stage pipeline candidates when it reports first-quarter earnings.
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoPomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) and certain officers. The class action ...
